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Adjusting for nonlipid risk factors (age, randomized treatment assignment, smoking status, menopausal status, hormone use, blood pressure, diabetes mellitus, and body mass index), hazard ratios and 95% confidence intervals for quintiles 2 to 5 versus quintile 1 of NMR-derived triglycerides were 1.51 (1.13-2.01), 1.71 (1.30 -2.26), 1.61 (1.23-2.11), and 2.31 (1.79 -3.00), respectively, P for trend Ͻ0.001, whereas for chemically measured triglycerides they were 1.34 (0.98 -1.83), 1.87 (1.39 -2.50), 1.89 (1.42-2.52), and 2.58 (1.95-3.41), respectively, P for trend Ͻ0.001. Similarly adjusted hazard ratios and 95% confidence intervals for NMR-derived HDL cholesterol quintiles 2 to 5 versus quintile 1 were 0.84 (0.69 -1.02), 0.78 (0.64 -0.96), 0.63 (0.51-0.77), and 0.66 (0.54 -0.81), respectively, P for trend Ͻ0.001, and for chemically measured HDL cholesterol they were 0.85 (0.71-1.03), 0.70 (0.58 -0.86), 0.59 (0.48 -0.73), and 0.52 (0.42-0.64), respectively, P for trend Ͻ0.001. In sum, NMR-derived HDL cholesterol and triglycerides predicted incident cardiovascular disease in this large study of initially healthy women to a magnitude that was comparable with, but not superior to, the chemical lipid measurements.
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